[EN] IMIDAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH CELL CYCLE DYSREGULATION<br/>[FR] DÉRIVÉS D'IMIDAZOLE POUR UTILISATION DANS LE TRAITEMENT DE MALADIES ASSOCIÉES À UNE DÉRÉGULATION DU CYCLE CELLULAIRE
申请人:UNIV OF PATRAS
公开号:WO2017203303A1
公开(公告)日:2017-11-30
The present invention provides imidazole derivatives according to formula (I), their enantiomers, stereoisomers, salts and hydrites thereof, for use in the treatment of diseases associated with cell cycle dysregulation, wherein R1, R2, R3, R4, R5, R7 and R8 are as defined in the claims. Also provided for use in the treatment of said diseases are pharmaceutical compositions comprising the compounds of the present invention in combination with one or more pharmaceutically acceptable carriers, solvents or excipients. Said diseases that are associated with cell cycle dysregulation are selected, among others, from a group comprising cancer, hamartoma, inflammatory disease, haematological disorder, viral disease with the potential of inducing carcinogenesis, metabolic disorder, progeroid syndrome, atherosclerosis, and vasculoproliferative disorder.